Merck & Co.
213 E Grand Ave, South San Francisco, CA
33 Avenue Louis Pasteur, Boston, MA
320 Bent St, Cambridge, MA
33 Avenue Louis Pasteur, Boston, MA
320 Bent St, Cambridge, MA
NEWS
The company notes that this decision has no effect on other indications for Keytruda.
On Thursday, the company said the U.S. Food and Drug Administration wants to see additional data beyond the Phase III study announced last year.
Merck said the acquisition adds a pipeline of drug candidates that target a broad range of autoimmune diseases.
Agilent is one of seven health care companies to make the fourth annual list of 100 companies compiled by the publication.
The combination of Keytruda and Lenvima was compared to Lenvima plus everolimus versus Pfizer’s Sutent (sunitinib) for first-line treatment of patients with advanced renal cell carcinoma (RCC).
The U.S. FDA Oncologic Drugs Advisory Committee voted against recommending the drug as neoadjuvant treatment for high-risk, early-stage triple-negative breast cancer (TNBC) in combination with chemotherapy after surgery, at least for now.
It was a busy week for clinical trial updates. Here’s a look.
A new report shows Merck’s anti-baldness drug Propecia (finasteride) has been linked to more than 700 incidences of suicide and suicidal thoughts, side effects that both Merck and U.S. regulators allegedly knew about since 2011.
Merck Chief Executive Officer Kenneth C. Frazier is stepping down from his role atop the helm of the pharma giant on June 30 after nearly 30 years with the company.
JOBS
IN THE PRESS